We are live on ! Find out more
CYTK icon

Cytokinetics
CYTK

122 hedge funds and large institutions have $380M invested in Cytokinetics in 2018 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 46 increasing their positions, 34 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

35% more repeat investments, than reductions

Existing positions increased: 46 | Existing positions reduced: 34

22% more capital invested

Capital invested by funds: $311M → $380M (+$69.1M)

1.52% more ownership

Funds ownership: 69.19% → 70.71% (+1.5%)

5% more call options, than puts

Call options by funds: $917K | Put options by funds: $875K

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

3% less funds holding

Funds holding: 126 → 122 (-4)

18% less first-time investments, than exits

New positions opened: 14 | Existing positions closed: 17

Holders
122
Holders Change
-4
Holders Change %
-3.17%
% of All Funds
2.79%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
14
Increased
46
Reduced
34
Closed
17
Calls
$917K
Puts
$875K
Net Calls
+$42K
Net Calls Change
+$182K

Top Buyers

Rank Fund Capital Flow
1
BlackRock
BlackRock
New York
+$6.05M
2
GPP
Great Point Partners
Connecticut
+$5.9M
3
Invesco
Invesco
Georgia
+$2.84M
4
SDIC
South Dakota Investment Council
South Dakota
+$1.46M
5
Dimensional Fund Advisors
Dimensional Fund Advisors
Texas
+$1.29M

Top Sellers

Rank Fund Capital Flow
1
BI
BVF Inc
California
-$2.92M
2
Millennium Management
Millennium Management
New York
-$1.87M
3
Goldman Sachs
Goldman Sachs
New York
-$1.13M
4
Allianz Asset Management
Allianz Asset Management
Germany
-$952K
5
PA
Pinnacle Associates
New York
-$875K
Name Holding Trade Value Shares
Change 		Change in
Stake
Zurich Cantonal Bank
101
Zurich Cantonal Bank
Switzerland
$18K – – –
BNP Paribas Financial Markets
102
BNP Paribas Financial Markets
France
$15.1K – – –
LIA
103
LS Investment Advisors
Michigan
$15K – – –
Bank of Montreal
104
Bank of Montreal
Ontario, Canada
$12K -$80 -10 -0.8%
MOACM
105
Mutual of America Capital Management
New York
$10K +$6.91K +861 +460%
SWA
106
Sutton Wealth Advisors
Florida
$9.47K +$7.71K +961 New
GWM
107
Geneos Wealth Management
Colorado
$9K – – –
MAM
108
Meeder Asset Management
Ohio
$9K +$7.63K +951 New
JA
109
JOYN Advisors
Georgia
$8K -$1.19K -148 -15%
Federated Hermes
110
Federated Hermes
Pennsylvania
$5K – – –
FDCDDQ
111
Federation des caisses Desjardins du Quebec
Quebec, Canada
$3.94K – – –
Daiwa Securities Group
112
Daiwa Securities Group
Japan
$3K – – –
LJHT
113
Laurie J. Hall Trustee
$3K – – –
GEA
114
Glen Eagle Advisors
New Jersey
$1.23K – – –
FGAM
115
Financial Gravity Asset Management
Texas
$1K -$48 -6 -5%
HR
116
Howe & Rusling
New York
$1K – – –
FHB
117
First Hawaiian Bank
Hawaii
$1K +$778 +97 New
US Bancorp
118
US Bancorp
Minnesota
$1K +$1.16K +144 New
Allianz Asset Management
119
Allianz Asset Management
Germany
– -$952K -114,691 Closed
PAM
120
Panagora Asset Management
Massachusetts
– -$812K -97,813 Closed
VRS
121
Virginia Retirement Systems
Virginia
– -$552K -66,500 Closed
Citadel Advisors
122
Citadel Advisors
Florida
– -$518K -64,601 Closed
Susquehanna International Group
123
Susquehanna International Group
Pennsylvania
– -$294K -36,686 Closed
FRM
124
Fox Run Management
Connecticut
– -$263K -31,627 Closed
DS
125
DRW Securities
Illinois
– -$222K -26,797 Closed
2 3 4
5
6

CYTK Hedge Fund Activity: Q3 2018 in Review

122 of the 4,374 institutional investors tracked by Wall St. Rank reported a position in Cytokinetics (CYTK) for Q3 2018, worth a combined $380M — up 22% from $311M a quarter earlier.

Sellers outnumbered buyers: 17 funds closed out of CYTK and 14 opened new positions — a net loss of 3 holders — while 34 trimmed existing stakes and 46 added.

The largest buyer was BlackRock, adding an estimated $6.05M. The largest seller was BVF Inc, cutting an estimated $2.92M.

  • 122 institutional investors held Cytokinetics (CYTK) as of Q3 2018, down from 126 in Q2 2018.
  • Funds reported $380M of Cytokinetics stock for Q3 2018, up 22% quarter-over-quarter.
  • 14 funds opened new Cytokinetics positions in Q3 2018 and 17 closed out, a net change of -3 holders.
  • The largest Cytokinetics buyer in Q3 2018 was BlackRock, an estimated $6.05M added.
  • The largest Cytokinetics seller in Q3 2018 was BVF Inc, an estimated $2.92M sold.

Based on aggregated 13F filings for Q3 2018.